Segment information - Information by Segment on Current Cost of Supplies Basis (Details) - USD ($) $ in Millions |
12 Months Ended |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Disclosure of operating segments [line items] |
|
|
|
Revenue |
$ 316,620
|
$ 381,314
|
$ 261,504
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
3,758
|
3,930
|
3,913
|
Interest and other income, of which: |
2,838
|
915
|
7,056
|
Interest income |
2,313
|
1,046
|
511
|
Net gains/(losses) on sale and revaluation of non-current assets and businesses |
257
|
642
|
5,995
|
Other |
268
|
(773)
|
550
|
Total expenditure |
290,556
|
321,386
|
242,828
|
Production and manufacturing expenses |
25,240
|
25,518
|
23,822
|
Selling, distribution and administrative expenses |
13,433
|
12,883
|
11,328
|
Research and development expenses |
1,287
|
1,075
|
815
|
Exploration expenses |
1,750
|
1,712
|
1,423
|
Depreciation, depletion and amortisation charge, of which: |
31,290
|
18,529
|
26,921
|
Impairment losses |
8,947
|
2,313
|
4,065
|
Impairment reversals |
(762)
|
(6,177)
|
(214)
|
Interest expense |
4,673
|
3,181
|
3,607
|
Taxation charge/(credit) (CCS basis) |
13,194
|
21,497
|
8,391
|
Other revenue |
15,607
|
11,708
|
126
|
Impairment losses on property, plant and equipment |
8,182
|
1,799
|
3,894
|
Goodwill |
635
|
361
|
167
|
Intangible assets other than goodwill |
130
|
153
|
4
|
Reversal of impairment loss recognised in profit or loss, property, plant and equipment |
627
|
6,177
|
214
|
Intangible assets other than goodwill |
135
|
0
|
0
|
Decrease through write-off, financial assets |
|
1,126
|
|
Purchase contract |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Reversal of losses (gains) on sales contracts |
2,074
|
7,201
|
4,892
|
Sales contract |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Reversal of losses (gains) on sales contracts |
(4,689)
|
(9,815)
|
(4,824)
|
CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Taxation charge/(credit) (CCS basis) |
203
|
(444)
|
(808)
|
CCS earnings |
20,281
|
41,562
|
17,482
|
Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
60,373
|
80,778
|
50,680
|
Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
272,441
|
340,980
|
229,364
|
Total expenditure |
39,960
|
39,476
|
35,965
|
Production and manufacturing expenses |
25,240
|
25,518
|
23,822
|
Selling, distribution and administrative expenses |
13,433
|
12,883
|
11,328
|
Research and development expenses |
1,287
|
1,075
|
815
|
Exploration expenses |
1,750
|
1,712
|
1,423
|
Depreciation, depletion and amortisation charge, of which: |
31,290
|
18,529
|
26,921
|
Impairment losses |
8,947
|
2,313
|
4,065
|
Impairment reversals |
(762)
|
(6,177)
|
(214)
|
Interest expense |
4,673
|
3,181
|
3,607
|
Integrated Gas |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
37,645
|
54,751
|
29,922
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
1,951
|
1,219
|
1,933
|
Interest and other income, of which: |
137
|
(714)
|
1,596
|
Interest income |
6
|
43
|
0
|
Net gains/(losses) on sale and revaluation of non-current assets and businesses |
(22)
|
101
|
1,610
|
Other |
153
|
(858)
|
(14)
|
Taxation charge/(credit) (CCS basis) |
2,803
|
5,899
|
2,648
|
Reversal of impairment loss recognised in profit or loss, property, plant and equipment |
325
|
3,449
|
|
Integrated Gas | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
7,046
|
22,212
|
8,060
|
Integrated Gas | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
11,560
|
18,412
|
8,072
|
Integrated Gas | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
27,356
|
37,785
|
20,188
|
Total expenditure |
4,823
|
5,237
|
4,526
|
Production and manufacturing expenses |
4,529
|
4,907
|
4,194
|
Selling, distribution and administrative expenses |
168
|
218
|
231
|
Research and development expenses |
126
|
112
|
101
|
Exploration expenses |
216
|
240
|
122
|
Depreciation, depletion and amortisation charge, of which: |
8,903
|
2,211
|
5,908
|
Impairment losses |
3,472
|
115
|
723
|
Impairment reversals |
(324)
|
(3,449)
|
(204)
|
Interest expense |
146
|
84
|
71
|
Upstream |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
6,475
|
8,352
|
9,182
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
768
|
2,111
|
632
|
Interest and other income, of which: |
671
|
726
|
4,592
|
Interest income |
27
|
22
|
37
|
Net gains/(losses) on sale and revaluation of non-current assets and businesses |
209
|
437
|
4,130
|
Other |
435
|
267
|
425
|
Taxation charge/(credit) (CCS basis) |
8,377
|
14,070
|
6,057
|
Impairment losses on property, plant and equipment |
|
320
|
|
Reversal of impairment loss recognised in profit or loss, property, plant and equipment |
203
|
2,504
|
|
Upstream | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
8,528
|
16,222
|
9,603
|
Upstream | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
41,230
|
52,285
|
35,789
|
Upstream | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
7,890
|
10,666
|
9,094
|
Total expenditure |
9,845
|
10,365
|
10,322
|
Production and manufacturing expenses |
9,186
|
9,676
|
9,797
|
Selling, distribution and administrative expenses |
163
|
233
|
186
|
Research and development expenses |
496
|
456
|
339
|
Exploration expenses |
1,534
|
1,472
|
1,301
|
Depreciation, depletion and amortisation charge, of which: |
12,463
|
10,334
|
13,485
|
Impairment losses |
1,360
|
950
|
920
|
Impairment reversals |
(206)
|
(2,504)
|
(9)
|
Interest expense |
507
|
345
|
333
|
Marketing |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
108,858
|
120,638
|
83,494
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
548
|
237
|
385
|
Interest and other income, of which: |
76
|
(104)
|
278
|
Interest income |
9
|
0
|
3
|
Net gains/(losses) on sale and revaluation of non-current assets and businesses |
16
|
(186)
|
285
|
Other |
51
|
82
|
(10)
|
Taxation charge/(credit) (CCS basis) |
819
|
903
|
903
|
Marketing | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
2,950
|
2,133
|
3,535
|
Marketing | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
624
|
606
|
254
|
Marketing | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
94,614
|
108,012
|
70,745
|
Total expenditure |
9,336
|
8,383
|
7,501
|
Production and manufacturing expenses |
949
|
810
|
950
|
Selling, distribution and administrative expenses |
8,137
|
7,351
|
6,384
|
Research and development expenses |
250
|
222
|
167
|
Exploration expenses |
0
|
0
|
0
|
Depreciation, depletion and amortisation charge, of which: |
2,335
|
1,900
|
1,700
|
Impairment losses |
420
|
480
|
129
|
Impairment reversals |
(1)
|
(151)
|
(1)
|
Interest expense |
52
|
46
|
27
|
Chemicals and Products |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
118,781
|
144,342
|
116,448
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
590
|
374
|
989
|
Interest and other income, of which: |
61
|
244
|
37
|
Interest income |
57
|
24
|
36
|
Net gains/(losses) on sale and revaluation of non-current assets and businesses |
(61)
|
282
|
(24)
|
Other |
65
|
(62)
|
25
|
Taxation charge/(credit) (CCS basis) |
(198)
|
935
|
(210)
|
Impairment losses on property, plant and equipment |
|
257
|
|
Chemicals and Products | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
1,530
|
4,515
|
404
|
Chemicals and Products | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
2,252
|
2,684
|
1,890
|
Chemicals and Products | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
102,396
|
127,521
|
103,294
|
Total expenditure |
11,483
|
11,362
|
10,347
|
Production and manufacturing expenses |
7,908
|
7,583
|
6,815
|
Selling, distribution and administrative expenses |
3,323
|
3,592
|
3,375
|
Research and development expenses |
252
|
187
|
157
|
Exploration expenses |
0
|
0
|
0
|
Depreciation, depletion and amortisation charge, of which: |
6,411
|
3,289
|
5,485
|
Impairment losses |
2,787
|
356
|
2,248
|
Impairment reversals |
(90)
|
(73)
|
0
|
Interest expense |
62
|
22
|
44
|
Renewables and Energy Solutions |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
44,819
|
53,190
|
22,415
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
(96)
|
(7)
|
(27)
|
Interest and other income, of which: |
75
|
57
|
200
|
Interest income |
12
|
(2)
|
4
|
Net gains/(losses) on sale and revaluation of non-current assets and businesses |
110
|
8
|
(6)
|
Other |
(47)
|
51
|
202
|
Taxation charge/(credit) (CCS basis) |
1,303
|
(303)
|
(342)
|
Renewables and Energy Solutions | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
3,038
|
(1,059)
|
(1,514)
|
Renewables and Energy Solutions | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
4,707
|
6,791
|
4,675
|
Renewables and Energy Solutions | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
40,170
|
57,024
|
26,048
|
Total expenditure |
3,831
|
3,590
|
2,745
|
Production and manufacturing expenses |
2,610
|
2,520
|
2,098
|
Selling, distribution and administrative expenses |
1,058
|
972
|
596
|
Research and development expenses |
163
|
98
|
51
|
Exploration expenses |
0
|
0
|
0
|
Depreciation, depletion and amortisation charge, of which: |
1,159
|
777
|
326
|
Impairment losses |
908
|
412
|
45
|
Impairment reversals |
(141)
|
0
|
0
|
Interest expense |
4
|
2
|
0
|
Corporate |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
42
|
41
|
43
|
Share of profit/(loss) of joint ventures and associates (CCS basis) |
(3)
|
(4)
|
1
|
Interest and other income, of which: |
1,818
|
706
|
353
|
Interest income |
2,202
|
959
|
431
|
Net gains/(losses) on sale and revaluation of non-current assets and businesses |
5
|
0
|
0
|
Other |
(389)
|
(253)
|
(78)
|
Taxation charge/(credit) (CCS basis) |
90
|
(7)
|
(665)
|
Corporate | CCS earnings |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
CCS earnings |
(2,811)
|
(2,461)
|
(2,606)
|
Corporate | Inter-segment |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Revenue |
0
|
0
|
0
|
Corporate | Operating segments |
|
|
|
Disclosure of operating segments [line items] |
|
|
|
Third-party and inter-segment purchases (CCS basis) |
15
|
(28)
|
(5)
|
Total expenditure |
642
|
539
|
524
|
Production and manufacturing expenses |
58
|
22
|
(32)
|
Selling, distribution and administrative expenses |
584
|
517
|
556
|
Research and development expenses |
0
|
0
|
0
|
Exploration expenses |
0
|
0
|
0
|
Depreciation, depletion and amortisation charge, of which: |
19
|
18
|
17
|
Impairment losses |
0
|
0
|
0
|
Impairment reversals |
0
|
0
|
0
|
Interest expense |
$ 3,902
|
$ 2,682
|
$ 3,132
|